首页> 外国专利> Maternal chelation for embryo, fetal and infant benefit

Maternal chelation for embryo, fetal and infant benefit

机译:母体螯合对胚胎,胎儿和婴儿有益

摘要

This invention teaches the use of chelating agents to diagnose and treat metal toxins in a patient. Chelation agents are given to the mother for the benefit of the baby. Metal toxins such as lead, arsenic, mercury, tin, antimony, aluminum and others are known to cause miscarriages, birth defects, maldevelopment of the organs and tissues and maldevelopment of the brain. Chelation treatments of the mother can prevent these problems in the embryo, fetus and infant. Removal of lead and mercury and other toxins allows improved development of the offspring, both during the chelation and after the chelation is discontinued. Determining whether a mother who has just delivered a baby has elevated levels of heavy metals can also be used to identify the elevated metals of the mother as a possible cause of birth defects.
机译:本发明教导了螯合剂在诊断和治疗患者中的金属毒素中的用途。为了母亲的利益,将螯合剂给予母亲。已知金属毒素(例如铅,砷,汞,锡,锑,铝和其他毒素)会导致流产,先天缺陷,器官和组织发育不良以及大脑发育不良。母亲的螯合治疗可以预防胚胎,胎儿和婴儿出现这些问题。在螯合过程中和中止螯合后,去除铅,汞和其他毒素可以改善后代的发育。确定刚分娩的母亲是否体内重金属含量升高也可以用来确定母亲体内金属含量升高是出生缺陷的可能原因。

著录项

  • 公开/公告号US10322100B2

    专利类型

  • 公开/公告日2019-06-18

    原文格式PDF

  • 申请/专利权人 PATRICK JAMES BAGGOT;

    申请/专利号US201715437094

  • 发明设计人 PATRICK JAMES BAGGOT;

    申请日2017-02-20

  • 分类号A61K31/185;A61K31/194;A61K31/727;A61K31/198;G01N33/493;G01N33/84;

  • 国家 US

  • 入库时间 2022-08-21 12:16:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号